Genetic testing is increasingly becoming a pivotal part of cancer assessments, especially for cancers with a known hereditary component. By identifying specific genetic mutations, healthcare providers can tailor treatment plans and offer targeted therapies that are more effective and have fewer side effects. Additionally, genetic information can be valuable for family members who may be at increased risk.
